Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maritsa Stephenson
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0009-4333-0564
Observed ORCID:
0009-0009-4333-0564
OpenAlex ID:
A5036786324
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors
2023
·
Elizabeth S. Duke
, Diana Bradford
, et al.
·
Clinical Cancer Research
·
106
PDF
FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer
2022
·
Elizabeth S. Duke
, Amy K. Barone
, et al.
·
Clinical Cancer Research
·
60
FDA Approval Summary: Vorasidenib for IDH -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery
2025
·
Michael I. Barbato
, Amy K. Barone
, et al.
·
Clinical Cancer Research
·
30
Show more works
View as search
Works count:
3
Citation count:
196
H-index:
3
I10-index:
3
Year
Topic
Type